Immunoglobulin and T-cell receptor gene rearrangements as PCR-based targets are stable markers for monitoring minimal residual disease in acute lymphoblastic leukemia after stem cell transplantation

被引：8
作者：
Kreyenberg, H. [1 ]
Eckert, C. [2 ]
Yarkin, Y. [3 ]
Reising, M. [1 ]
Willasch, A. [1 ]
Handgretinger, R. [3 ]
Kremens, B. [4 ]
von Stackelberg, A. [2 ]
Henze, G. [2 ]
Klingebiel, T. [1 ]
Bader, P. [1 ]
机构：
[1] Goethe Univ Frankfurt, Dept Paediat Oncol Haematol & Haemostaseol, Childrens Hosp, Frankfurt, Germany
[2] Humboldt Univ, Dept Paediat Oncol Haematol, Charite Hosp, Berlin, Germany
[3] Univ Tubingen, Dept Haematol Oncol, Childrens Univ Hosp, Tubingen, Germany
[4] Univ Essen Gesamthsch, Dept Pediat Haematol Oncol & Endocrinol, Essen, Germany
来源：
LEUKEMIA | 2009年 / 23卷 / 07期
关键词：
CONCERTED ACTION; RELAPSE; PROTOCOLS; CHILDREN; PRIMERS;
D O I：
10.1038/leu.2009.72
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1355 / 1358
页数：5
相关论文
共 50 条
  • [31] Donor-Derived CD19-Targeted T Cell Infusion Eliminates B Cell Acute Lymphoblastic Leukemia Minimal Residual Disease with No Response to Donor Lymphocytes after Allogeneic Hematopoietic Stem Cell Transplantation
    Cheng, Yifei
    Chen, Yuhong
    Yan, Chenhua
    Wang, Yu
    Zhao, Xiangyu
    Chen, Yao
    Han, Wei
    Xu, Lanping
    Zhang, Xiaohui
    Liu, Kaiyan
    Wang, Shasha
    Chang, Lungji
    Xiao, Lei
    Huang, Xiaojun
    ENGINEERING, 2019, 5 (01) : 150 - 155
  • [32] Hematopoietic Stem Cell Transplantation for Adult Philadelphia-Negative Acute Lymphoblastic Leukemia in the First Complete Remission in the Era of Minimal Residual Disease
    Bourlon, Christianne
    Lacayo-Lenero, Dennis
    Inclan-Alarcon, Sergio I.
    Demichelis-Gomez, Roberta
    CURRENT ONCOLOGY REPORTS, 2018, 20 (04)
  • [33] Multiple CAR-T cell therapy for acute B-cell lymphoblastic leukemia after hematopoietic stem cell transplantation: A case report
    Deng, Lei
    Yu, Xiaolin
    Wu, Qian
    Song, Xiaochen
    Li, Wenjun
    Hou, Yixi
    Liu, Yue
    Wang, Jing
    Tian, Jun
    Zuo, Xiaona
    Zhou, Fang
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [34] Consolidative allogeneic hematopoietic stem cell transplantation after chimeric antigen receptor T-cell therapy for relapsed/refractory B-cell acute lymphoblastic leukemia: who? When? Why?
    Jiang, Huiwen
    Hu, Yu
    Mei, Heng
    BIOMARKER RESEARCH, 2020, 8 (01)
  • [35] Pseudoprogression of extramedullary disease in relapsed acute lymphoblastic leukemia after CAR T-cell therapy
    Huang, Jie
    Rong, Liucheng
    Wang, Enxiu
    Fang, Yongjun
    IMMUNOTHERAPY, 2021, 13 (01) : 5 - 10
  • [36] Effectiveness of T-Cell Replete Haploidentical Hematopoietic Stem Cell Transplantation for Refractory/Relapsed B Cell Acute Lymphoblastic Leukemia in Children and Adolescents
    Sano, Hideki
    Mochizuki, Kazuhiro
    Kobayashi, Shogo
    Ohara, Yoshihiro
    Takahashi, Nobuhisa
    Kudo, Shingo
    Waragai, Tomoko
    Ikeda, Kazuhiko
    Ohto, Hitoshi
    Kikuta, Atsushi
    FRONTIERS IN PEDIATRICS, 2021, 9
  • [37] Impact of pre-transplantation minimal residual disease (MRD) on the outcome of Allogeneic hematopoietic stem cell transplantation for acute leukemia
    Shen, Xing
    Pan, Jing
    Qi, Chenchen
    Feng, Yuan
    Wu, Hanxin
    Qian, Sixuan
    Lu, Hua
    Chen, Lijuan
    Li, Jianyong
    Miao, Kourong
    Qiu, Hairong
    Zhu, Han
    HEMATOLOGY, 2021, 26 (01) : 295 - 300
  • [38] Digital droplet PCR-based chimerism analysis for monitoring of hematopoietic engraftment after allogeneic stem cell transplantation
    Mika, Thomas
    Baraniskin, Alexander
    Ladigan, Swedlana
    Wulf, Gerald
    Dierks, Sascha
    Haase, Detlef
    Schork, Karin
    Turewicz, Michael
    Eisenacher, Martin
    Schmiegel, Wolff
    Schroers, Roland
    Klein-Scory, Susanne
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2019, 41 (05) : 615 - 621
  • [39] Standardized next-generation sequencing of immunoglobulin and T-cell receptor gene recombinations for MRD marker identification in acute lymphoblastic leukaemia; a EuroClonality-NGS validation study
    Brueggemann, Monika
    Kotrova, Michaela
    Knecht, Henrik
    Bartram, Jack
    Boudjogrha, Myriam
    Bystry, Vojtech
    Fazio, Grazia
    Fronkova, Eva
    Giraud, Mathieu
    Grioni, Andrea
    Hancock, Jeremy
    Herrmann, Dietrich
    Jimenez, Cristina
    Krejci, Adam
    Moppett, John
    Reigl, Tomas
    Salson, Mikael
    Scheijen, Blanca
    Schwarz, Martin
    Songia, Simona
    Svaton, Michael
    van Dongen, Jacques J. M.
    Villarese, Patrick
    Wakeman, Stephanie
    Wright, Gary
    Cazzaniga, Giovanni
    Davi, Frederic
    Garcia-Sanz, Ramon
    Gonzalez, David
    Groenen, Patricia J. T. A.
    Hummel, Michael
    Macintyre, Elizabeth A.
    Stamatopoulos, Kostas
    Pott, Christiane
    Trka, Jan
    Darzentas, Nikos
    Langerak, Anton W.
    LEUKEMIA, 2019, 33 (09) : 2241 - 2253
  • [40] Monitoring of minimal residual disease by quantitative WT1 gene expression following reduced intensity conditioning allogeneic stem cell transplantation in acute myeloid leukemia
    Candoni, Anna
    Toffoletti, Eleonora
    Gallina, Roberto
    Simeone, Erica
    Chiozzotto, Marianna
    Volpetti, Stefano
    Fanin, Renato
    CLINICAL TRANSPLANTATION, 2011, 25 (02) : 308 - 316
12345